← All Sponsors

SPONSOR

7 Hills Pharma, LLC

Total Trials

1

Recruiting

1

Phases

Phase 1, Phase 2

Conditions studied: Advanced Cancer Advanced Solid Tumor Melanoma Metastasis Pleural Mesothelioma Renal Cell Carcinoma MSI-High Mismatch Repair Deficiency Colorectal Cancer Hepatocellular Carcinoma

NCT06362369 Phase 1, Phase 2

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Advanced Cancer